Retatrutide, a novel dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) target, is showing promising results in early human assessments . Ongoing inquiry https://sociallawy.com/story11930259/retatrutide-emerging-research-and-projected-medical-uses